Status:
COMPLETED
Characteristics of Patients Declining INKA Trial Participation
Lead Sponsor:
Marius Henriksen
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to compare baseline characteristics of overweight knee OA patients accepting vs. declining enrolment in the INKA trial (NCT05172843) to explore if enrolled patients diff...
Eligibility Criteria
Inclusion
- Age 18 or more
- A clinical and radiological diagnosis of knee OA
- BMI ≥ 30 kg/m2
- Motivated for weight loss as by the provided program
- Signed informed consent.
Exclusion
- The scheduled surgery is for revision of an existing prosthesis
- Planned surgery for more than one knee within the observation period
- KA indication due to sequelae of fracture(s)
- Injection of medication or substances in the target knee within 3 months prior to participation
- Immuno-inflammatory arthritis as cause of the knee OA
- Current systemic treatment with glucocorticoids equivalent to \> 7.5 mg of prednisolone/day
- Previous or planned obesity surgery
- Inability to understand or read Danish incl. instructions and questionnaires
- Any other condition or impairment that, in the opinion of the investigator (or his/her delegate), makes a potential participant unsuitable for participation or which obstruct participation.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT05215678
Start Date
February 1 2022
End Date
September 30 2023
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Parker Institute, Frederiksberg Hospital
Copenhagen, Denmark, 2000